{
  "pdf": "Pain Management Handbook 2019. palliative (PDF).pdf",
  "pdf_path": "Pain Management Handbook 2019. palliative (PDF).pdf",
  "headings": [
    {
      "page": 1,
      "top": 95.6,
      "level": 1,
      "font_size": 24.0,
      "text": "Paediatric Acute Pain",
      "children": []
    },
    {
      "page": 1,
      "top": 123.2,
      "level": 1,
      "font_size": 24.0,
      "text": "Management Handbook",
      "children": [
        {
          "page": 2,
          "top": 99.4,
          "level": 2,
          "font_size": 13.980000000000018,
          "text": "CONTENTS",
          "children": []
        },
        {
          "page": 4,
          "top": 115.4,
          "level": 2,
          "font_size": 13.980000000000018,
          "text": "1. INTRODUCTION",
          "children": []
        },
        {
          "page": 5,
          "top": 77.6,
          "level": 2,
          "font_size": 13.980000000000018,
          "text": "2. PRINCIPLES OF ANALGESIC ADMINISTRATION IN CHILDREN",
          "children": []
        },
        {
          "page": 6,
          "top": 77.6,
          "level": 2,
          "font_size": 13.980000000000018,
          "text": "3. MANAGING PAIN USING SIMPLE AND ORAL ANALGESICS",
          "children": [
            {
              "page": 6,
              "top": 129.3,
              "level": 3,
              "font_size": 13.980000000000018,
              "text": "3.1 Paracetamol",
              "children": []
            },
            {
              "page": 7,
              "top": 145.1,
              "level": 3,
              "font_size": 13.980000000000018,
              "text": "3.2 Diclofenac (Voltaren)",
              "children": []
            },
            {
              "page": 7,
              "top": 314.1,
              "level": 3,
              "font_size": 13.980000000000018,
              "text": "3.3 Ibuprofen (Brufen)",
              "children": []
            },
            {
              "page": 8,
              "top": 183.0,
              "level": 3,
              "font_size": 13.980000000000018,
              "text": "3.4 Parecoxib (Dynastat)",
              "children": []
            },
            {
              "page": 9,
              "top": 67.3,
              "level": 3,
              "font_size": 13.980000000000018,
              "text": "3.3 Celecoxib",
              "children": []
            },
            {
              "page": 9,
              "top": 274.3,
              "level": 3,
              "font_size": 13.980000000000018,
              "text": "3.5 Tramadol",
              "children": []
            },
            {
              "page": 10,
              "top": 683.0,
              "level": 3,
              "font_size": 13.980000000000018,
              "text": "3.6 Oral Morphine Preparations",
              "children": []
            },
            {
              "page": 11,
              "top": 94.3,
              "level": 3,
              "font_size": 12.0,
              "text": "Morphine Elixir",
              "children": []
            },
            {
              "page": 11,
              "top": 212.7,
              "level": 3,
              "font_size": 12.0,
              "text": "Morphine Tabs \u2013 Immediate Release (Sevredol)",
              "children": []
            },
            {
              "page": 11,
              "top": 331.2,
              "level": 3,
              "font_size": 12.0,
              "text": "Morphine Tabs \u2013 Controlled Release (LA Morph)",
              "children": []
            },
            {
              "page": 11,
              "top": 687.0,
              "level": 3,
              "font_size": 13.980000000000018,
              "text": "3.7 Oxycodone",
              "children": []
            },
            {
              "page": 12,
              "top": 233.4,
              "level": 3,
              "font_size": 12.0,
              "text": "Oxycodone \u2013 Immediate Release (Oxynorm, Endone)",
              "children": []
            },
            {
              "page": 13,
              "top": 373.2,
              "level": 3,
              "font_size": 13.980000000000018,
              "text": "3.8 Codeine Phosphate",
              "children": []
            }
          ]
        },
        {
          "page": 14,
          "top": 77.6,
          "level": 2,
          "font_size": 13.980000000000018,
          "text": "4. MANAGING PAIN USING PARENTERAL ANALGESICS",
          "children": [
            {
              "page": 14,
              "top": 129.3,
              "level": 3,
              "font_size": 13.980000000000018,
              "text": "4.1 Protocol for Intermittent IV Opioids",
              "children": []
            },
            {
              "page": 14,
              "top": 541.0,
              "level": 3,
              "font_size": 13.980000000000018,
              "text": "4.2 Protocol for Intravenous Opioid Infusions",
              "children": []
            },
            {
              "page": 16,
              "top": 324.1,
              "level": 3,
              "font_size": 13.980000000000018,
              "text": "4.3 Protocol for Nurse Controlled Analgesia (NCA)",
              "children": []
            },
            {
              "page": 17,
              "top": 496.4,
              "level": 3,
              "font_size": 13.980000000000018,
              "text": "4.4 Protocol for Patient Controlled Analgesia (PCA)",
              "children": []
            },
            {
              "page": 18,
              "top": 597.5,
              "level": 3,
              "font_size": 13.980000000000018,
              "text": "4.5 Protocol for Subcutaneous Morphine Boluses",
              "children": []
            }
          ]
        },
        {
          "page": 20,
          "top": 115.4,
          "level": 2,
          "font_size": 13.980000000000018,
          "text": "5. MANAGING PAIN USING EPIDURALS",
          "children": []
        },
        {
          "page": 24,
          "top": 77.6,
          "level": 2,
          "font_size": 13.980000000000018,
          "text": "6. MANAGING PAIN USING REGIONAL INFUSIONS",
          "children": []
        },
        {
          "page": 27,
          "top": 77.6,
          "level": 2,
          "font_size": 13.980000000000018,
          "text": "7. MANAGING PAIN USING ENTONOX",
          "children": []
        },
        {
          "page": 29,
          "top": 101.6,
          "level": 2,
          "font_size": 13.980000000000018,
          "text": "8. MANAGING ADVERSE EFFECTS & TROUBLESHOOTING",
          "children": [
            {
              "page": 29,
              "top": 153.3,
              "level": 3,
              "font_size": 13.980000000000018,
              "text": "8.1 LA Toxicity",
              "children": []
            },
            {
              "page": 29,
              "top": 462.0,
              "level": 3,
              "font_size": 12.0,
              "text": "8.1.1 Management of Impending LA Toxicity",
              "children": []
            },
            {
              "page": 30,
              "top": 66.7,
              "level": 3,
              "font_size": 12.0,
              "text": "8.1.2 Cardiac Resuscitation in the Event of Suspected LA Toxicity",
              "children": []
            },
            {
              "page": 30,
              "top": 232.7,
              "level": 3,
              "font_size": 13.980000000000018,
              "text": "8.2 Management of Common Opioid Side-Effects",
              "children": []
            },
            {
              "page": 30,
              "top": 275.8,
              "level": 3,
              "font_size": 12.0,
              "text": "8.2.1 Management of Overdose",
              "children": []
            },
            {
              "page": 30,
              "top": 545.7,
              "level": 3,
              "font_size": 12.0,
              "text": "8.2.2 Management of Pruritus",
              "children": []
            },
            {
              "page": 31,
              "top": 94.9,
              "level": 3,
              "font_size": 13.980000000000018,
              "text": "8.3 Management of Nausea & Vomiting",
              "children": []
            },
            {
              "page": 31,
              "top": 476.8,
              "level": 3,
              "font_size": 12.0,
              "text": "8.3.1 PONV Prophylaxis",
              "children": []
            },
            {
              "page": 32,
              "top": 268.5,
              "level": 3,
              "font_size": 12.0,
              "text": "8.3.2 PONV Treatment",
              "children": []
            },
            {
              "page": 33,
              "top": 67.3,
              "level": 3,
              "font_size": 13.980000000000018,
              "text": "8.4 Management of Common Epidural Problems",
              "children": []
            },
            {
              "page": 33,
              "top": 110.4,
              "level": 3,
              "font_size": 12.0,
              "text": "8.4.1 Epidural Disconnection",
              "children": []
            },
            {
              "page": 33,
              "top": 381.0,
              "level": 3,
              "font_size": 12.0,
              "text": "\u2022",
              "children": []
            },
            {
              "page": 33,
              "top": 394.8,
              "level": 3,
              "font_size": 12.0,
              "text": "\u2022",
              "children": []
            },
            {
              "page": 33,
              "top": 462.1,
              "level": 3,
              "font_size": 12.0,
              "text": "8.4.2 Inadequate Analgesia",
              "children": []
            },
            {
              "page": 34,
              "top": 67.3,
              "level": 3,
              "font_size": 13.980000000000018,
              "text": "8.5 Troubleshooting",
              "children": []
            }
          ]
        },
        {
          "page": 35,
          "top": 77.6,
          "level": 2,
          "font_size": 13.980000000000018,
          "text": "9. MONITORING",
          "children": [
            {
              "page": 35,
              "top": 129.3,
              "level": 3,
              "font_size": 13.980000000000018,
              "text": "9.1 Pain Assessment & Measurement",
              "children": []
            },
            {
              "page": 36,
              "top": 81.1,
              "level": 3,
              "font_size": 13.980000000000018,
              "text": "9.2 Monitoring",
              "children": []
            },
            {
              "page": 36,
              "top": 150.6,
              "level": 3,
              "font_size": 12.0,
              "text": "9.2.1 Opioids",
              "children": []
            },
            {
              "page": 36,
              "top": 590.4,
              "level": 3,
              "font_size": 12.0,
              "text": "9.2.2 Epidurals and Regional Infusions",
              "children": []
            },
            {
              "page": 37,
              "top": 81.1,
              "level": 3,
              "font_size": 13.980000000000018,
              "text": "9.3 Some Normal Physiological Values for Children 0-16 Years",
              "children": []
            }
          ]
        },
        {
          "page": 38,
          "top": 77.6,
          "level": 2,
          "font_size": 13.980000000000018,
          "text": "10. MANAGING PAIN FROM BURNS",
          "children": []
        },
        {
          "page": 40,
          "top": 77.6,
          "level": 2,
          "font_size": 13.980000000000018,
          "text": "11. OTHER ANALGESIC MEDICATIONS",
          "children": [
            {
              "page": 40,
              "top": 129.3,
              "level": 3,
              "font_size": 13.980000000000018,
              "text": "11.1 Fentanyl Patches",
              "children": []
            },
            {
              "page": 41,
              "top": 283.2,
              "level": 3,
              "font_size": 13.980000000000018,
              "text": "11.2 Gabapentin",
              "children": []
            },
            {
              "page": 42,
              "top": 416.3,
              "level": 3,
              "font_size": 13.980000000000018,
              "text": "11.3 Amitriptyline",
              "children": []
            },
            {
              "page": 43,
              "top": 94.9,
              "level": 3,
              "font_size": 13.980000000000018,
              "text": "11.4 Diazepam",
              "children": []
            },
            {
              "page": 43,
              "top": 316.8,
              "level": 3,
              "font_size": 13.980000000000018,
              "text": "11.5 Intranasal Fentanyl",
              "children": []
            }
          ]
        },
        {
          "page": 44,
          "top": 77.6,
          "level": 2,
          "font_size": 13.980000000000018,
          "text": "12. PREOPERATIVE MEDICATIONS",
          "children": [
            {
              "page": 44,
              "top": 129.3,
              "level": 3,
              "font_size": 13.980000000000018,
              "text": "12.1 Topical Local Anaesthetics",
              "children": []
            },
            {
              "page": 44,
              "top": 515.7,
              "level": 3,
              "font_size": 13.980000000000018,
              "text": "12.2 Premedications",
              "children": []
            }
          ]
        },
        {
          "page": 47,
          "top": 77.6,
          "level": 2,
          "font_size": 13.980000000000018,
          "text": "13. MANAGING PAIN FOLLOWING TONSILLECTOMY",
          "children": [
            {
              "page": 47,
              "top": 594.9,
              "level": 3,
              "font_size": 12.0,
              "text": "Note:",
              "children": []
            }
          ]
        },
        {
          "page": 49,
          "top": 77.6,
          "level": 2,
          "font_size": 13.980000000000018,
          "text": "14. MANAGING PAIN FOLLOWING SCOLIOSIS SURGERY",
          "children": [
            {
              "page": 49,
              "top": 219.0,
              "level": 3,
              "font_size": 13.980000000000018,
              "text": "14.1 Intraoperative Analgesia",
              "children": []
            },
            {
              "page": 49,
              "top": 365.3,
              "level": 3,
              "font_size": 13.980000000000018,
              "text": "14.2 Postoperative Analgesia",
              "children": []
            }
          ]
        },
        {
          "page": 51,
          "top": 77.6,
          "level": 2,
          "font_size": 13.980000000000018,
          "text": "15. INITIAL TREATMENT OF CHRONIC PAIN IN CHILDREN",
          "children": [
            {
              "page": 51,
              "top": 244.3,
              "level": 3,
              "font_size": 13.980000000000018,
              "text": "15.1 Types of Chronic Pain in Children",
              "children": []
            },
            {
              "page": 51,
              "top": 709.1,
              "level": 3,
              "font_size": 13.97999999999999,
              "text": "15.2 Management",
              "children": []
            },
            {
              "page": 52,
              "top": 205.8,
              "level": 3,
              "font_size": 12.0,
              "text": "15.2.1 Referal to the Pain Service",
              "children": []
            },
            {
              "page": 52,
              "top": 390.5,
              "level": 3,
              "font_size": 12.0,
              "text": "15.2.2 Initial approach and non-drug treatments",
              "children": []
            },
            {
              "page": 53,
              "top": 413.4,
              "level": 3,
              "font_size": 12.0,
              "text": "15.2.3 Drugs",
              "children": []
            }
          ]
        },
        {
          "page": 55,
          "top": 77.6,
          "level": 2,
          "font_size": 13.980000000000018,
          "text": "16. PALLIATIVE CARE, TERMINAL ILLNESS AND END-OF-LIFE",
          "children": [
            {
              "page": 55,
              "top": 320.2,
              "level": 3,
              "font_size": 13.980000000000018,
              "text": "16.1 Key Aspects of Care",
              "children": []
            },
            {
              "page": 55,
              "top": 529.7,
              "level": 3,
              "font_size": 13.980000000000018,
              "text": "16.2 Symptom Management",
              "children": []
            },
            {
              "page": 55,
              "top": 557.8,
              "level": 3,
              "font_size": 12.0,
              "text": "16.2.1 General Approach",
              "children": []
            },
            {
              "page": 56,
              "top": 66.7,
              "level": 3,
              "font_size": 12.0,
              "text": "16.2.2 Pain Management",
              "children": []
            },
            {
              "page": 57,
              "top": 220.6,
              "level": 3,
              "font_size": 13.980000000000018,
              "text": "16.3 Resources",
              "children": []
            },
            {
              "page": 57,
              "top": 286.8,
              "level": 3,
              "font_size": 12.0,
              "text": "(",
              "children": []
            }
          ]
        }
      ]
    }
  ]
}
